6-hydroxynorketamine has been researched along with morphine in 2 studies
| Studies (6-hydroxynorketamine) | Trials (6-hydroxynorketamine) | Recent Studies (post-2010) (6-hydroxynorketamine) | Studies (morphine) | Trials (morphine) | Recent Studies (post-2010) (morphine) |
|---|---|---|---|---|---|
| 38 | 2 | 36 | 44,270 | 5,200 | 8,695 |
| Protein | Taxonomy | 6-hydroxynorketamine (IC50) | morphine (IC50) |
|---|---|---|---|
| Delta-type opioid receptor | Mus musculus (house mouse) | 0.2939 | |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 0.2278 | |
| Kappa-type opioid receptor | Mus musculus (house mouse) | 0.0828 | |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0385 | |
| Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0545 | |
| Mu-type opioid receptor | Homo sapiens (human) | 0.122 | |
| Delta-type opioid receptor | Homo sapiens (human) | 0.1199 | |
| Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.9308 | |
| Kappa-type opioid receptor | Homo sapiens (human) | 0.655 | |
| Mu-type opioid receptor | Mus musculus (house mouse) | 0.3305 | |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.202 | |
| Beta-2 adrenergic receptor | Cavia porcellus (domestic guinea pig) | 0.25 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jokinen, V; Kalso, EA; Lilius, TO; Niemi, M; Rauhala, PV; Viisanen, H | 1 |
| Chen, Y; Lai, J; Wei, S; Yan, P; Zhou, Q; Zhu, Y | 1 |
2 other study(ies) available for 6-hydroxynorketamine and morphine
| Article | Year |
|---|---|
Interactions of (2S,6S;2R,6R)-Hydroxynorketamine, a Secondary Metabolite of (R,S)-Ketamine, with Morphine.
Topics: Analgesics, Opioid; Anesthetics, Dissociative; Animals; Behavior, Animal; Brain; Disease Models, Animal; Drug Interactions; Drug Tolerance; Ketamine; Male; Morphine; Motor Activity; Nociception; Nociceptive Pain; Pain Threshold; Rats, Sprague-Dawley | 2018 |
Ketamine metabolite alleviates morphine withdrawal-induced anxiety via modulating nucleus accumbens parvalbumin neurons in male mice.
Topics: Analgesics, Opioid; Animals; Anxiety; Anxiety Disorders; Ketamine; Male; Mice; Morphine; Neurons; Nucleus Accumbens; Parvalbumins; Potassium | 2023 |